These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antipsychotic drug doses in a schizophrenia inpatient unit. Galletly CA Aust N Z J Psychiatry; 1992 Dec; 26(4):574-6. PubMed ID: 1362051 [TBL] [Abstract][Full Text] [Related]
24. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists. Heresco-Levy U; Brom D; Greenberg D Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179 [TBL] [Abstract][Full Text] [Related]
25. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia]. Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T Encephale; 2002; 28(2):129-38. PubMed ID: 11972139 [TBL] [Abstract][Full Text] [Related]
26. Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia. Citrome L CNS Spectr; 2012 Nov; 17 Suppl 1():1-9. PubMed ID: 23448847 [TBL] [Abstract][Full Text] [Related]
27. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients. Glazer WM; Ereshefsky L J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015 [TBL] [Abstract][Full Text] [Related]
28. [Long-term treatment of outpatients with depot neuroleptics (author's transl)]. Saameli W Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584 [No Abstract] [Full Text] [Related]
29. [Is depot formulation a long-term optimal treatment option?]. Musch A Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031 [No Abstract] [Full Text] [Related]
30. Depot fluphenazine decanoate and enanthate for schizophrenia. David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872 [TBL] [Abstract][Full Text] [Related]
31. [Results of a survey on the use of delayed-action neuroleptics in psychiatry]. Bourin M; Venisse JL; Lecuyer F Encephale; 1990; 16(5):363-9. PubMed ID: 1979942 [TBL] [Abstract][Full Text] [Related]
32. [Psychological aspects of depot treatment of schizophrenic syndromes]. Jacobsson L; Odling H Lakartidningen; 1980 Oct; 77(40):3522-6. PubMed ID: 6109045 [No Abstract] [Full Text] [Related]
33. Impace of depot neuroleptics on psychiatry. Corbett L Minn Med; 1979 Feb; 62(2):97-100. PubMed ID: 34788 [No Abstract] [Full Text] [Related]
34. Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study. Simon P; Fermanian J; Ginestet D; Goujet MA; Péron-Magnan P Arch Gen Psychiatry; 1978 Jul; 35(7):893-7. PubMed ID: 28102 [TBL] [Abstract][Full Text] [Related]